MAP Pharma prices IPO, aims for $92M haul
September 21, 2007 | David P. Hamilton
See our story on this Mountain View, Calif., specialty-pharmaceutical company in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Vascular Architects sold for a pittance
Previous Story: Complete Genomics raises second round for high-speed sequencing
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












